Want to join the conversation?
Steven Fisher of UBS asks about EPS growth going forward. $JEC said it is confident in improving fundamentals of delivering projects and becoming more efficient in cost and capital. The company believes it has opportunities to drive improvement, optimize costs and improve margins going into 2017.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?